Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 31;15(1):295.
doi: 10.3390/cancers15010295.

Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines

Affiliations
Review

Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines

Amr Mohamed et al. Cancers (Basel). .

Abstract

Appendiceal neuroendocrine neoplasms (ANENs) usually present as incidental findings at the time of appendectomy for acute appendicitis. They are rare, accounting for only 0.5-1% of intestinal neoplasms; they are found in 0.3-0.9% of all appendectomy specimens. They are usually sporadic tumors. There are several histological types including well-differentiated neuroendocrine tumors (NETs), poorly differentiated neuroendocrine carcinomas (NECs), and mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs). Histologic differentiation and the grade of well-differentiated NETs correlate with clinical behavior and prognosis. Management varies based on differentiation, aggressiveness, and metastatic potential. There is debate about the optimal surgical management for localized appendiceal NETs that are impacted by many factors including the tumor size, the extent of mesoappendiceal spread, lymphovascular invasion and perineural involvement. In addition, the data to guide therapy in metastatic disease are limited due to the paucity of these tumors. Here, we review the current advances in the management of ANENs within the context of a multidisciplinary approach to these tumors.

Keywords: appendix; management; neoplasms; neuroendocrine.

PubMed Disclaimer

Conflict of interest statement

None of the authors has a conflict of interest to declare.

Figures

Figure 1
Figure 1
Post-treatment Follow-up After Surgery for Appendiceal Neuroendocrine Neoplasms (ANENs).
Figure 2
Figure 2
Surgical Treatment of Localized ANENs after Simple Appendectomy.
Figure 3
Figure 3
Therapeutic Strategy for Metastatic Well-Differentiated ANENs based on histological grades.
Figure 4
Figure 4
Management of Poorly Differentiated ANEC.
Figure 5
Figure 5
Management of mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs).

References

    1. Van De Moortele M., De Hertogh G., Sagaert X., Van Cutsem E. Appendiceal cancer: A review of the literature. Acta Gastroenterol. Belg. 2020;83:441–448. - PubMed
    1. Moertel C.G., Weiland L.H., Nagorney D.M., Dockerty M.B. Carcinoid Tumor of the Appendix: Treatment and Prognosis. N. Eng. J. Med. 1987;317:1699–1701. doi: 10.1056/NEJM198712313172704. - DOI - PubMed
    1. McCusker M.E., Coté T.R., Clegg L.X., Sobin L.H. Primary malignant neoplasms of the appendix. Cancer. 2002;94:3307–3312. doi: 10.1002/cncr.10589. - DOI - PubMed
    1. McGory M.L., Maggard M.A., Kang H., O’Connell J.B., Ko C.Y. Malignancies of the Appendix: Beyond Case Series Reports. Dis. Colon Rectum. 2005;48:2264–2271. doi: 10.1007/s10350-005-0196-4. - DOI - PubMed
    1. Benedix F., Reimer A., Gastinger I., Mroczkowski P., Lippert H., Kube R. Primary appendiceal carcinoma–Epidemiology, surgery and survival: Results of a German multi-center study. Eur. J. Surg. Oncol. (EJSO) 2010;36:763–771. doi: 10.1016/j.ejso.2010.05.025. - DOI - PubMed

LinkOut - more resources